Top Tech Analyst Previews Earnings for Oclaro and Oracle

PRINCETON, N.J., Sept. 16, 2013 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on technology stocks, has issued updated outlooks for Oclaro (Nasdaq: OCLR), and Oracle (NYSE: ORCL).

Over the past ten years, over a thousand Wall Street analysts, stock brokers, institutional investment managers, and even tech industry executives, have counted on Next Inning editor Paul McWilliams to be their guide for investing in the tech sector.  With his vast network of field contacts, McWilliams provides an unmatched combination of tech experience, fundamental investment knowledge and street level intelligence.

McWilliams spent a decades-long career in the technology industry and has earned a reputation for his skill in communicating complex technology trends to individual investors and professional analysts alike. His reports have won over readers with their ability to unravel the complexities of the industry and, more importantly, identify which companies are likely to be the winners and losers as technology trends change.

McWilliams' newest installment of his acclaimed State of Tech series of reports will cover dozens of technology stocks and dive deep into a number of exciting, emerging tech trends, well ahead of the Wall Street curve. Trial subscribers will receive the detailed report for free, no strings attached. This report is a must read for investors and analysts focusing on technology right now.

To get ahead of the Wall Street curve and receive Next Inning's Q3 2013 State of Tech report, you are invited to take a free, 21-day, no obligation trial with Next Inning, by visiting following link:

https://www.nextinning.com/subscribe/index.php?refer=prn1621

Other topics discussed in the latest reports include:

Oclaro: Following McWilliams call to sell Oclaro last year when it was trading for $1.85 we saw the stock fall to a low of $0.88.  However, the price recovered sharply following the announcement that Oclaro would sell yet another of its product lines to II-VI.  This appears to at least soothe worries about an imploding balance sheet.  However, it doesn't mean Oclaro will suddenly become a cash flow positive business.  What does McWilliams think about Oclaro's new CEO and his plans for the proceeds from the recent deal?  Is this a turnaround story worthy of consideration, more a wide-eyed gamble, or do we really have enough information at this juncture to tell?

-- Oracle: When Oracle fell into the high $20s last June, McWilliams wrote that the stock was clearly oversold.  We've since seen the price of Oracle recover somewhat, but certainly not to the mid-$30s where it traded ahead of its last quarterly report.  What specific trends does McWilliams see developing that he thinks will favor Oracle?  Is Oracle well positioned to be a big winner as the "Big Data" paradigm takes hold? What is McWilliams expecting from Oracle's earnings report this week and what is his price target for the stock?

Founded in September 2002, Next Inning's model portfolio has returned 299% since its inception versus 86% for the S&P 500.

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks.  Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926.  Interested parties may visit adviserinfo.sec.gov for additional information.  Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515

SOURCE Indie Research Advisors, LLC